Program

Nov. 7 (Thu)

Scientific Symposium 1

Current status of precision medicine in oncology area
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue BAEKDU
Chair
  • Min-Hee RYU (Asan Medical Center, Korea)
  • Emmanuel S. ANTONARAKIS (The Johns Hopkins University School of Medicine, USA)
    		•
    Speaker
    1. 1.Precision medicine in NSCLC: Current interpretation of biomarkers from NGS
      Myung-Ju AHN (Samsung Medical Center, Korea)
    2. 2.Precision medicine in advanced prostate cancer
      Emmanuel S. ANTONARAKIS (The Johns Hopkins University, USA)
    3. 3.Gastric cancer in the era of precision medicine
      Jeeyun LEE (Samsung Medical Center, Korea)

    Scientific Symposium 2

    IT biotech & digital health in oncology
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue HANRA 1
    Chair
  • Hyun Choel CHUNG (Severance Hospital, Korea)
  • Joon Beom SEO (Asan Medical Center, Korea)
    		•
    Speaker
    1. 1.Artificial Intelligence in Medicine
      Yoon Sup CHOI (DHP, Korea)
    2. 2.Artificial intelligence for lung cancer imaging
      Kyu-Hwan JUNG (Vuno, Korea)
    3. 3.AI technologies for diagnosis of rare genetic cancer
      Changwon KEUM (3 Billion, Korea)
    4. 4.Deep learning for cancer precision medicine
      Seong-Eui HONG (Theragen, Korea)

    Scientific Symposium 3

    Emerging strategies in immunotherapy
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue HANRA 2
    Chair
  • Dae Ho LEE (Asan Medical Center, Korea)
  • Aung NAING (MD Anderson Cancer Center, USA)
    		•
    Speaker
    1. 1.Promises and challenges of immunotherapy
      Aung NAING (MD Anderson Cancer Center, USA)
    2. 2.Emerging immuno-oncology targets and combination therapies
      Cathy PIETANZA (MSD, USA)
    3. 3.Engineered resistance to checkpoint molecule suppression augments anti-tumor function of chimeric antigen receptor T cells against thoracic cancers
      Edmund K. MOON (University of Pennsylvania, USA)

    Scientific Symposium 4

    State of the art on systemic therapy in HCC
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue HANRA 3
    Chair
  • Baek-Yeol RYOO (Asan Medical Center, Korea)
  • Winnie YEO (The Chinese University of Hong Kong, Hong Kong)
    		•
    Speaker
    1. 1.Targeted therapy and biomarkers in hepatocellular carcinoma
      Changhoon YOO (Asan Medical Center, Korea)
    2. 2.Immunotherapy and biomarkers in hepatocellualar carcinoma
      Hong Jae CHON (CHA Bundang Medical Center, Korea)
    3. 3.Future of clinical trials in hepatocellular carcinoma
      Stephen L. CHAN (The Chinese University of Hong Kong, Hong Kong)

    Plenary Lecture 1

    Date & Time Nov. 7 (Thu), 10:30-11:10 Venue BAEKDU
    Chair Young-Hyuck IM (Samsung Medical Center, Korea)
    Speaker Targeting DNA repair in breast cancer
    Andrew TUTT (The Institute of Cancer Research, UK)

    Presidential Symposium

    Date & Time Nov. 7 (Thu), 11:10-11:50 Venue BAEKDU
    Chair Joung Soon JANG (Chung-Ang University Hospital, Korea)
    Speaker The VHL tumor suppressor gene: Insights into oxygen sensing and cancer
    William G. KAELIN, Jr. (Dana-Farber Cancer Institute, USA)

    Luncheon Symposium 1

    Date & Time Nov. 7 (Thu), 11:50-12:30 Venue BAEKDU
    Chair Keun Seok LEE (National Cancer Center, Korea)
    Speaker New horizon of neoadjuvant and adjuvant treatment in HER2-positive breast cancer
    Yeon Hee PARK (Samsung Medical Center, Korea)

    Luncheon Symposium 2

    Date & Time Nov. 7 (Thu), 11:50-12:30 Venue HANRA 1&2
    Chair Keunchil PARK (Samsung Medical Center, Korea)
    Speaker New perspectives for the future treatment option in non small cell lung cancer
    Natasha B. LEIGHL (Princess Margaret Cancer Centre, Canada)

    Satellite Symposium 1

    How can we improve the outcome of pancreatic cancer?
    Date & Time Nov. 7 (Thu), 11:50-12:30 Venue HANRA 3
    Chair Joung Soon JANG (Chung-Ang University Hospital, Korea)
    Speaker
    1. 1.Recent clinical trials in adjuvant therapy for resected pancreatic cancer
      Dong-Hoe KOO (Kangbuk Samsung Hospital, Korea)
    2. 2.FOLFIRINOX in localized pancreatic cancer: It's time to talk 'Cure' in this disease
      Changhoon YOO (Asan Medical Center, Korea)

    Special Symposium

    Research, write, publish
    Date & Time Nov. 7 (Thu), 12:50-13:50 Venue BAEKDU
    Chair
  • Masahiro TSUBOI (National Cancer Center Hospital East, Japan)
  • Jae Hong SEO (Korea University Guro Hospital, Korea)
    		•
    Speaker
    1. 1.How to get your manuscript published in a high impact factor journal
      Alex A. ADJEI (Mayo Clinic, USA)
    2. 2.Efforts in doing good translational research as a junior faculty in Korea
      Young Seok JU (KAIST, Korea)

    Multidisciplinary Oncology Team Education Session 1 *KOR

    Immuno-oncologic therapy and pharmacologic management
    Date & Time Nov. 7 (Thu), 12:50-13:50 Venue HANRA 3
    Chair
  • Ae-Ryoung PARK (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
  • Sun Young KIM (Asan Medical Center, Korea)
    		•
    Speaker
    1. 1.Immune checkpoint inhibitors
      Jung Ae SEO (National Cancer Center, Korea)
    2. 2.Identification and management of toxicities related to immuno-oncologic therapy
      Juhyang CHEON (Yeungnam University Hospital, Korea)
    3. 3.Oncology pharmacist’s role in immuno-oncologic therapy
      Soyeon HONG (Seoul National University Bundang Hospital, Korea)

    ASCO/KSMO Joint Symposium

    Progress in precision medicine through global collaboration
    I. Utilization of NGS to improve patient care
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue BAEKDU
    Chair
  • Yung-Jue BANG (Seoul National University Hospital, Korea)
  • Subha MADHAVAN (Georgetown University, USA)
    		•
    Speaker
    1. 1.Precision genomics-based patients’ care - ASCO’s TAPUR study
      Edward Sanghyun KIM (Levine Cancer Institute, USA)
    2. 2.Clinical applications of NGS in Korea
      Tae-You KIM (Seoul National University Hospital, Korea)
    3. 3.Global collaboration in genomic data sharing and use
      Subha MADHAVAN (Georgetown University, USA)
    II. Integrated platform for precision medicine
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue BAEKDU
    Chair
  • Tae-You KIM (Seoul National University Hospital, Korea)
  • Damon Hostin (Precision Medicine Alliance of Common Spirit Health (Former), USA)
    		•
    Speaker
    1. 1.Integrated precision medicine platform for data-sharing in the USA
      Damon Hostin (Precision Medicine Alliance of Common Spirit Health (Former), USA)
    2. 2.How can we incorporate NGS data-sharing platform for precision medicine in Korea?
      Woong Yang PARK (Samsung Medical Center, Korea)
    3. 3.KSMO-KCSG Korean precision medicine networking group initiative
      Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)

    Scientific Symposium 5

    Modulating microenvironment for cancer treatment
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue HANRA 1
    Chair
  • Jin-Hyuk CHOI (Ajou University Hospital, Korea)
  • Stephen L. CHAN(The Chinese University of Hong Kong, Hong Kong)
    		•
    Speaker
    1. 1.STING signaling regulates immune-vascular crosstalk to enhance anti-tumor immunity
      Chan KIM (CHA Bundang Medical Center, Korea)
    2. 2.Inhibiting metastatic progression by targeting the tumor microenvironment
      Sandra RYEOM (UPENN, USA)
    3. 3.Leverages advanced technologies to investigate microbiomes and their clinical impact
      Julia OH (The Jackson Laboratory, USA)

    KOSRO/KSMO Joint Symposium

    The promise of combining RT and Immunotherapy
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue HANRA 2
    Chair
  • In Ah KIM (Seoul National University Bundang Hospital, Korea)
  • Adam RABEN (Christiana Care Health System, USA)
    		•
    Speaker
    1. 1.Radiotherapy and Immunotherapy - New strategy for better outcome
      Adam RABEN (Christiana Care Health System, USA)
    2. 2.Radiotherapy and Immunotherapy - On ongoing clinical trial
      Jin Ho KIM (Seoul National University Hospital, Korea)
    3. 3.Toxicities of the combination of radiotherapy and immunotherapy
      Keun-Wook LEE (Seoul National University Bundang Hospital, Korea)

    Multidisciplinary Oncology Team Education Session 2 *KOR

    Oncology nursing care in immune-oncology and targeted agent
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue HANRA 3
    Chair
  • Yeon Hee PARK (Samsung Medical Center, Korea)
  • Onam OK (Samsung Medical Center, Korea)
    		•
    Speaker
    1. 1.Principles of clinical advances of molecular targeted agent
      Moon Ki CHOI (National Cancer Center, Korea)
    2. 2.Principles of clinical advances of immune-oncology
      Eun Joo KANG (Korea University Guro Hospital, Korea)
    3. 3.Management of molecular targeted agent-related AEs
      Gyeong-Won LEE (Gyeongsang National University Hospital, Korea)
    4. 4.Management of immune-related AEs
      Yun-Gyoo LEE (Kangbuk Samsung Hospital, Korea)

    Scientific Symposium 6

    Translational Research - Biomarker studies to achieve desired clinical applications
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue HANRA 1
    Chair
  • Patrick TAN (Duke-NUS Medical School, Singapore)
  • Yeul Hong KIM (Korea University Anam Hospital, Korea)
    		•
    Speaker
    1. 1.Development of CDK 4/6 inhibitor for solid tumors
      Richard FINN (UCLA, USA)
    2. 2.Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma: Insights for novel targeted therapies
      Qiang PAN-HAMMARSTRÖM (Karolinska Institutet, Sweden)
    3. 3.Genomic predictors of disease progression in gastrointestinal cancer
      Patrick TAN (Duke-NUS Medical School, Singapore)

    Scientific Symposium 7

    GY cancer multimodality treatment
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue HANRA 2
    Chair
  • Yong Man KIM (Asan Medical Center, Korea)
  • KyungHae JUNG (Asan Medical Center, Korea)
    		•
    Speaker
    1. 1.The role of PARPi in ovarian cancer
      Keun Ho LEE (The Catholic University of Korea Seoul St. Mary's Hospital's Hospital, Korea)
    2. 2.Immuno-oncology for ovarian cancer
      Gun Min KIM (Yonsei Cancer Center, Korea)
    3. 3.Combination of PARP inhibitors and Immune checkpoint inhibitors in ovarian cancer 
      Jung-Min LEE (National Cancer Institute, USA)
    4. 4.International collaboration in gynecologic cancer clinical research
      Elise C. KOHN (National Cancer Institute, USA)

    Satellite Symposium 2

    Changing the trajectory for patients with breast cancer
    Date & Time Nov. 7 (Thu), 17:30-18:30 Venue BAEKDU
    Chair Seock-Ah IM (Seoul National University Hospital, Korea)
    Speaker
    1. 1.From clinical trials to practice: CDK4/6 inhibitors for HR+ HER2- mBC treatment
      Richard FINN (UCLA, USA)
    2. 2.CDK4/6 inhibitors in future directions: Understanding resistance & Next sequence of therapies
      Kyong Hwa PARK (Korea University Anam Hospital, Korea)
    3. 3.Current unmet needs in TNBC and evolving therapeutic strategies
      Andrew TUTT (The Institute of Cancer Research, UK)

    Satellite Symposium 3

    Emerging targeted treatment for rare lung cancer
    Date & Time Nov. 7 (Thu), 17:30-18:30 Venue HANRA 1
    Chair Sang-We KIM (Asan Medical Center, Korea)
    Speaker
    1. 1.Targeting BRAF V600E NSCLC
      Se-Hoon LEE (Samsung Medical Center, Korea)
    2. 2.Optimizing treatment of neuroendocrine tumor in lung
      Shin-kyo YOON (Asan Medical Center, Korea)

    Satellite Symposium 4

    Mapping post-progression treatment options for patients with advanced GC or mCRC
    Date & Time Nov. 7 (Thu), 17:30-18:30 Venue HANRA 2
    Chair Min-Hee RYU (Asan Medical Center, Korea)
    Speaker
    1. 1.Clinical benefit of ramucirumab as second-line therapy in advanced gastric cancer
      Minkyu JUNG (Yonsei Cancer Center, Korea)
    2. 2.Role of Anti-angiogenic agents in mCRC and clinical practice in Japan
      Akitaka MAKIYAMA (Japan Community Healthcare Organization Kyushu Hospital, Japan)

    Satellite Symposium 5

    How to assess and treat BTcP in cancer patients?
    Date & Time Nov. 7 (Thu), 17:30-18:30 Venue HANRA 3
    Chair Sang Cheul OH (Korea University Guro Hospital, Korea)
    Speaker
    1. 1.Assessment, management, and barriers of breakthrough cancer pain: A nationwide study in Korea
      Su-Jin KOH (Ulsan University Hospital, Korea)
    2. 2.Individualized treatment strategies for breakthrough cancer pain
      Seonghoon SHIN (Kosin University Gospel Hospital, Korea)

    Satellite Symposium 6

    Navigating a new therapeutic era for Immune-oncology
    Date & Time Nov. 7 (Thu), 17:30-18:30 Venue BAEKJE 1
    Chair Jin-Hyoung KANG (Seoul St. Mary’s Hospital)
    Speaker
    1. 1.Elevating the treatment paradigm with Nivolumab in NSCLC
      Young Joo MIN (Ulsan University Hospital, Korea)
    2. 2.Rethinking the management of advanced RCC in an evolving therapeutic landscape
      Chan KIM (CHA Bundang Medical Center, Korea)

    Nov. 8 (Fri)

    Satellite Symposium 7

    Optimizing clinical application of new targeted agents in HCC
    Date & Time Nov. 8 (Fri), 08:00-08:50 Venue BAEKDU 1
    Chair Baek-Yeol RYOO (Asan Medical Center, Korea)
    Speaker
    1. 1.Optimizing clinical application of Lenvatinib as first line therapy in unresectable HCC
      Tatsuya YAMASHITA (Kanazawa University Hospital, Japan)
    2. 2.Clinical benefit of Cabozantinib as a new option in second line therapy in advanced HCC
      Lorenza RIMASSA (Humanitas University, Italy)

    Satellite Symposium 8

    New indication of immune-check point inhibitor PDL-1 antibody
    Date & Time Nov. 8 (Fri), 08:00-08:50 Venue BAEKDU 2
    Chair Jin-Hyoung KANG (Seoul St. Mary’s Hospital, Korea)
    Speaker
    1. 1.New indication of immune-check point inhibitor PDL-1 antibody
      Alexander D. GUMINSKI (The University of Sydney, Australia)

    Satellite Symposium 9

    Metastatic cancers and bone health management
    Date & Time Nov. 8 (Fri), 08:00-08:50 Venue BAEKDU 3
    Chair Jin Seok AHN (Samsung Medical Center, Korea)
    Speaker
    1. 1.Translate genetic insights into new therapies
      Yingli MA (Amgen Asia, China)
    2. 2.Bone-targeting agents in the era of novel therapeutics
      Alison STOPECK (Stony Brook Cancer Center, USA)

    Satellite Symposium 10

    New insights and clinical implications for the treatment of ALK+NSCLC
    Date & Time Nov. 8 (Fri), 08:00-08:50 Venue BAEKJE 1
    Chair Myung-Ju AHN (Samsung Medical Center, Korea)
    Speaker
    1. 1.Insights into mechanisms of resistance and characterizing oncogenic drivers in ALK+NSCLC
      James CH YANG (National Taiwan University Hospital, Taiwan)
    2. 2.Navigating options in second line
      Dae Ho LEE (Asan Medical Center, Korea)

    Scientific Symposium 8

    Partnering between biotechs and investigators in early phase drug development
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue BAEKDU 1
    Chair
  • Tae Won KIM (Asan Medical Center, Korea)
  • Stefan GLÜCK (GMA Oncology & Early Assets, USA)
    		•
    Speaker
    1. 1.How to navigate turbulent biotech as an investigator?
      James Jungkue LEE (Bridge Biotherapeutics, Inc., Korea)
    2. 2.PharmAbcine story and its Perspective in Oncology
      Jin-San YOO (PharmAbcine, Korea)
    3. 3.Microbiome meets Cancer and Immunology
      Hansoo PARK (Genome & Company, Korea)
    4. 4.Who are the preferred investigators for early phase clinical trials? (Global perspective)
      Helen Hyun Jung LEE (Samyang Biopharm USA, USA)

    Scientific Symposium 9

    Precision oncology and cancer epigenetics
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue BAEKDU 2
    Chair
  • Sung-Soo YOON (Seoul National University, Korea)
  • Choon Kiat Ong (National Cancer Centre Singapore, Singapore)
    		•
    Speaker
    1. 1.Identifying and targeting epigenetic defects in liver disease
      Keith D. ROBERTSON (Mayo Clinic, USA)
    2. 2.Elucidating methylation mechanism of recurrence in Korean HCC
      Young-Joon KIM (Yonsei University, Korea)
    3. 3.Epigenetic aberration of malignant lymphoma and its therapeutic application
      Young-Hyeh KO (Samsung Medical Center, Korea)

    KCSG/KSMO Joint Symposium

    Multidisciplinary efforts for awareness and minimizing toxicities from systemic cancer therapy
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue BAEKDU 3
    Chair
  • Eric LANCASTER (UPENN, USA)
  • Jin-Hyoung KANG (Seoul St. Mary’s Hospital, Korea)
    		•
    Speaker
    1. 1.Endocrinopathy
      Tae Jung OH (Seoul National University Bundang Hospital, Korea)
    2. 2.Cardiovascular toxicity of immune checkpoint inhibitors
      Joe-Elie SALEM (Sorbonne University, France)
    3. 3.Neurological toxicities of immune checkpoint inhibitor therapies
      Eric LANCASTER (UPENN, USA)
    4. 4.Real-world data of immune checkpoint inhibitors toxicities in Korean NSCLC patients: Is there any ethnic difference?
      Jin-Hyoung KANG (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)

    Plenary Lecture 2

    Date & Time Nov. 8 (Fri), 10:50-11:30 Venue BAEKDU
    Chair Kyung Hee LEE (Yeungnam University Hospital, Korea)
    Speaker Past, present and future of geriatric oncology
    Hans WILDIERS (University Hospitals Leuven, Belgium)

    Noe Kyeong Kim Memorial Award & Lecture

    Date & Time Nov. 8 (Fri), 11:30-12:10 Venue BAEKDU
    Chair Soon Nam LEE (Ewha Womans University Mokdong Hospital, Korea)
    Speaker NKK Memorial Award Lecture
    Keunchil PARK (Samsung Medical Center, Korea)

    Luncheon Symposium 3

    Date & Time Nov. 8 (Fri), 12:10-12:50 Venue BAEKDU
    Chair Sang-We KIM (Asan Medical Center, Korea)
    Speaker The new era of advanced NSCLC treatment: Time to navigate patient journey with optimal front-line treatment
    Myung-Ju AHN (Samsung Medical Center, Korea)

    Satellite Symposium 11

    What is being considered for continuum of care in metastatic colorectal cancer?
    Date & Time Nov. 8 (Fri), 12:10-13:00 Venue BAEKJE 1
    Chair Joong-Bae AHN (Yonsei Cancer Center, Korea)
    Speaker
    1. 1.How to make smart treatment decisions using the insights from biomarker data?
      Sun Young KIM (Asan Medical Center, Korea)
    2. 2.Optimal choice of the 2nd line treatment based on experience and guidelines
      Myung Ah LEE (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)

    Plenary Lecture 3

    Date & Time Nov. 8 (Fri), 10:50-11:30 Venue BAEKDU
    Chair Myung-Ju AHN (Samsung Medical Center, Korea)
    Speaker The reality versus potential of immune check-point inhibitors as cancer therapeutics
    Heather A. WAKELEE (Stanford University , USA)

    JSMO/KSMO Joint Symposium

    Clinical Trials in Asia: Opportunities and Challenges
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue BAEKDU 1
    Chair
  • Tae-You KIM (Seoul National University Hospital, Korea)
  • Hironobu MINAMI (Kobe University Hospital, Japan)
    		•
    Speaker
    1. 1.How to make the biopharma companies to decide to conduct clinical trials in Asia? -Realizing Asian-lead clinical development utilizing the cutting-edge platform SCRUM-Japan MONSTAR-SCREEN-
      Takayuki YOSHINO (National Cancer Center Hospital East, Japan)
    2. 2.Early phase 1 clinical research capabilities in Japan
      Toshio SHIMIZU (National Cancer Center Hospital Japan, Japan)
    3. 3.Early clinical research capabilities in Korea
      Do-Youn OH (Seoul National University Hospital, Korea)
    4. 4.JSMO-KSMO collaboration for clinical trials
      Sun Young RHA (Yonsei Cancer Center, Korea)

    Scientific Symposium 10

    Geriatric Oncology
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue BAEKDU 2
    Chair
  • Ravindran KANESVARAN (National Cancer Centre Singapore, Singapore)
  • Si-Young KIM (Kyung Hee University Hospital, Korea)
    		•
    Speaker
    1. 1.Geriatrics for oncologists
      Kwang-Il KIM (Seoul National University Hospital, Korea)
    2. 2.Predicting outcome of older patients with cancer – Sharing Korean experiences
      Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)
    3. 3.How to improve cancer care for older patients - Sharing Singaporian experiences
      Ravindran KANESVARAN (National Cancer Centre Singapore, Singapore)
    4. 4.Breast cancer in older women
      Hans WILDIERS (University Hospitals Leuven, Belgium)

    KSSO/KSMO Joint Symposium

    Evolving strategies for surgery and systemic therapy in the neoadjuvant treatment era
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue BAEKDU 3
    Chair
  • Paul F. MANSFIELD (MD Anderson Cancer Center, USA)
  • Jae Yong CHO (Gangnam Severance Hospital, Korea)
    		•
    Speaker
    1. 1.Neoadjuvant treatment for gastric cancer in Western countries
      Paul F. MANSFIELD (MD Anderson Cancer Center, USA)
    2. 2.Neoadjuvant treatment for gastric cancer in East Asian countries
      Masanori TERASHIMA (Shizuoka Cancer Center, Japan)
    3. 3.Conversion surgery in metastatic gastric cancer
      Eun-Kee SONG (Chonbuk National University Hospital, Korea)

    KSP/KSMO Joint Symposium

    Immune Biomarker
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue BAEKDU 1
    Chair
  • Patricia MARINELLO (MSD, USA)
  • Geon Kook LEE (National Cancer Center, Korea)
    		•
    Speaker
    1. 1.MSI-H in pan-tumor
      Patricia MARINELLO (MSD, USA)
    2. 2.TMB: the role in IO prediction
      Ji-hun KIM (Asan Medical Center, Korea)
    3. 3.PD-L1 in routine practice
      Tae-Jung KIM (The Catholic University of Korea Yeouido St. Mary's Hospital, Korea)
    4. 4.Multiplex immunoprofiling in cancer
      Hee Jin LEE (Asan Medical Center, Korea)

    Scientific Symposium 11

    Radiomics: Primer for medical oncologists
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue BAEKDU 2
    Chair
  • Seung Hong CHOI (Seoul National University Hospital, Korea)
  • Ho Yun LEE (Samsung Medical Center, Korea)
    		•
    Speaker
    1. 1.Radiomics and deep learning in differential diagnosis and molecular classification
      Ji Eun PARK (Asan Medical Center, Korea)
    2. 2.Radiomics and deep learning in monitoring treatment response
      Philipp KICKINGEREDER (Heidelberg University Hospital, Germany)
    3. 3.Oncologist's view of radiomics
      Kyu-pyo KIM (Asan Medical Center, Korea)
    4. 4.Radiomics in thoracic oncology
      Ho Yun LEE (Samsung Medical Center, Korea)

    Oncology Multi-disciplinary Symposium *KOR

    Multi-disciplinary Discussion on the Reimbursement Criteria of Imaging Studies in Cancer Patients
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue BAEKDU 3
    Chair Dong-Wan KIM (Seoul National University Hospital, Korea)
    Speaker
    1. 1.Past two years of collaborative multidisciplinary commitee among core society
      Young-Jin SUH (St. Vincent's Hospital, Korea)
    2. 2.Practical issues of using RECIST and iRECIST in clinical practice
      Kyung Won KIM (Asan Medical Center, Korea)
    3. 3.Evolving concepts in the treatment of oligoprogression
      Miso KIM (Seoul National University Hospital, Korea)
    4. 4.Current issues in the utilization of radiotherapy for oligometastatic disease
      Ik Jae LEE (Gangnam Severance Hospital, Korea)
    5. 4.The basis of precision medicine: Companion diagnosis and NGS
      Yoon-La CHOI (Samsung Medical Center, Korea)
    6. 5.Panel Discussion

    Multidisciplinary Oncology Team Education Session 3 *KOR

    CRC/CRA in clinical trial of precision medicine
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue BAEKJE 1
    Chair
  • Hwan Jung YUN (Chungnam National University Hospital, Korea)
  • Seok Yun KANG (Ajou University Hospital, Korea)
    		•
    Speaker
    1. 1.Recent trend of clinical trials in a precision medicine era
      Jeong Eun KIM (Asan Medical Center, Korea)
    2. 2.Real experience of a basket trial: K-basket trial
      Min Hwan KIM (Yonsei Cancer Center, Korea)
    3. 3.Real experience of an umbrella trial: TRIUMPH, a biomarker-integrated umbrella trial in H&N cancer
      Hee Kyung AHN (Gachon University Gil Medical Center, Korea)